This is a preprint.
Genome x Environment analysis of Sudden Unexpected Infant Death unveils etiologic heterogeneity and strong cannabis and genetic disease risks
- PMID: 41358299
- PMCID: PMC12676543
- DOI: 10.1101/2025.11.26.25341098
Genome x Environment analysis of Sudden Unexpected Infant Death unveils etiologic heterogeneity and strong cannabis and genetic disease risks
Abstract
Sudden Unexpected Infant Death (SUID), the third leading cause of infant death, has increasing incidence and multifactorial etiology. Identification of preventative interventions has hitherto been hindered by etiologic studies limited to genetic or environmental effects in isolation. Here we report a multifactorial genome x environment analysis of SUID risk. Births in San Diego County California from 2005-2018 were linked to hospital discharge summaries and death files, yielding 212 SUID cases and 620,392 infants alive at age 1 year. Whole genome sequencing (WGS) identified probable and possible genetic etiologies in 16% and 48% of SUID cases, respectively. Genetic risks were extremely heterogeneous with 144 loci contributing 173 risks in 57% of SUID cases. Genetic risk was very strong (Prevalence Risk Ratio, PRR >99) or strong (PRR 3.7 - 99) in 12% and 34% of SUID cases, respectively. Six of sixteen significant environmental risks lost significance when SUID cases without strong or very strong genetic risk were compared with infants alive at age 1 year, while SUID risk associated with prenatal cannabis increased from adjusted hazard ratio (aHR) 3.7 to 6.0, other substance abuse from aHR 2.6 to 3.5, and black race from aHR 1.9 to 2.5. Thus, genome x environment analysis of a large cohort unveiled etiologic heterogeneity and hidden SUID risks, highlighting cannabis and genetic diseases as strong risk factors. Since preventative or therapeutic interventions were available for 83% of genetic risks, newborn screening by WGS has potential for substantial SUID reduction. Educational campaigns for SUID should emphasize perinatal cannabis avoidance.
Conflict of interest statement
Declaration of interests: Erwin Frise is an employee and shareholder of GeneDx Inc. Mark Yandell is a shareholder of GeneDx Inc.
Figures
References
-
- Centers for Disease Control and Prevention (CDC): Sudden Unexpected Infant Death and Sudden Infant Death Syndrome: Data and Statistics. Available from: https://www.cdc.gov/sudden-infant-death/data-research/data/index.html Accessed 7/16/2025.
-
- Moon RY, Carlin RF, Hand I; TASK FORCE ON SUDDEN INFANT DEATH SYNDROME AND THE COMMITTEE ON FETUS AND NEWBORN. Sleep-Related Infant Deaths: Updated 2022 Recommendations for Reducing Infant Deaths in the Sleep Environment. Pediatrics. 2022. Jul 1;150(1):e2022057990. doi: 10.1542/peds.2022-057990. - DOI
-
- Bayes BJ. Letter: Prone infants and SIDS. N Engl J Med. 1974. Mar 21;290(12):693–4. doi: 10.1056/nejm197403212901223. - DOI
-
- Esmail A, Lambert PC, Jones DR, Mitchell EA. Prevalence of risk factors for sudden infant death syndrome in south east England before the 1991 national 'Back to Sleep' health education campaign. J Public Health Med. 1995. Sep;17(3):282–9. - PubMed
Publication types
Grants and funding
LinkOut - more resources
Full Text Sources